News

DAPT increases bleeding without decreasing mortality in patients with coronary disease and diabetes

February 2, 2021

In patients who have diabetes with known coronary disease but without prior MI or stroke, what is the effect of dual-antiplatelet therapy (DAPT) with aspirin and ticagrelor on cardiovascular outcomes and bleeding events?